methacholine chloride has been researched along with 2019 Novel Coronavirus Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chul-Ho, K; Guntupalli, SK; Hainy, ME; Helgeson, SA; Johnson, BD; Lim, KG; Niven, AS; Sajgalik, P; Scanlon, PD; Subat, YW; Torgerud, KD | 1 |
| Lim, KG; Meyer, TJ; Niven, AS; Scanlon, PD; Subat, YW; Torgerud, KD | 1 |
| El-Rahman, MKA; ElDin, NB; Hassan, SA; Moustafa, AA; Zaazaa, HE | 1 |
3 other study(ies) available for methacholine chloride and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Aerosol Generation and Mitigation During Methacholine Bronchoprovocation Testing: Infection Control Implications in the Era of COVID-19.
Topics: Aerosols; COVID-19; Humans; Infection Control; Methacholine Chloride; Nebulizers and Vaporizers; Pandemics; Particle Size; SARS-CoV-2 | 2021 |
Use of a Viral Filter to Reduce Exposure to Exhaled Aerosol Does Not Affect Methacholine Dose Delivery During Bronchoprovocation Testing.
Topics: Administration, Inhalation; Aerosols; Albuterol; Bronchodilator Agents; COVID-19; Equipment Design; Exhalation; Humans; Methacholine Chloride; Nebulizers and Vaporizers; Pandemics | 2022 |
Microfabricated potentiometric sensor for personalized methacholine challenge tests during the COVID-19 pandemic.
Topics: Biosensing Techniques; Bronchoconstrictor Agents; COVID-19; Humans; Methacholine Chloride; Pandemics; SARS-CoV-2 | 2021 |